95.010 Marijuana


Marijuana: The Texas Medical Association supports: (1) further adequate and well-controlled studies of marijuana and related cannabinoids for potential medical uses, particularly in patients with serious conditions for which preclinical, anecdotal, or controlled evidence suggests possible efficacy and for the application of such results to the understanding and treatment of disease (Committee on Addictive Diseases, p 115, A-94; reaffirmed CSA Rep. 4-A-04); (2) evidence-based strategies that will help to reduce use by children, adolescents, and pregnant women, and others who are at higher risk of adverse effects; (3) identifying resources for physicians on the research relating to marijuana for medical use and working with specialty societies to guide education and information that should be shared with patients; and (4) affirming the physician’s right to discuss with his or her patients any and all possible treatment options related to the patients’ health and clinical care, including the use of marijuana, without the threat to physician or patient of regulatory, disciplinary, or criminal sanctions. This should not be viewed as an endorsement of state-based medical cannabis programs, the legalization of marijuana, or that scientific evidence on the therapeutic use of cannabis meets the current standards for a prescription drug product (CSA Rep. 4-A-04; amended CSPH Rep. 2-A-14; amended CSPH Rep. 2-A-15).

Last Updated On

October 07, 2016